BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Diabetes Treatment With Glucobay in Combination With Sulfonylurea
- First Posted Date
- 2012-06-06
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Bayer
- Target Recruit Count
- 4564
- Registration Number
- NCT01613105
Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6784
- Registration Number
- NCT01606995
Qlaira Post-authorization Safety Study Related to Most Common Adverse Events in Mexican Women Who Wish to Avoid Pregnancy
Completed
- Conditions
- Contraception
- Interventions
- Drug: EV/DNG (Qlaira, BAY86-5027)
- First Posted Date
- 2012-05-21
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1
- Registration Number
- NCT01602770
Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Completed
- Conditions
- Non-valvular Atrial Fibrillation (NVAF)
- Interventions
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2019-05-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 741
- Registration Number
- NCT01598051
Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life
- First Posted Date
- 2012-05-10
- Last Posted Date
- 2015-07-10
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3006
- Registration Number
- NCT01595724
FR01 and FR20 IUS (Intrauterine System) Wearing Study
Phase 1
Completed
- Conditions
- Contraception
- First Posted Date
- 2012-05-09
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 90
- Registration Number
- NCT01595022
Survey of Prevalence of Loss of Appetite in Subject With Health Disorders
Completed
- Conditions
- Appetite
- Interventions
- Other: No Drug
- First Posted Date
- 2012-05-07
- Last Posted Date
- 2015-02-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 16629
- Registration Number
- NCT01592149
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
Completed
- Conditions
- Contraception
- Interventions
- Drug: Levonorgestrel (Mirena, BAY86-5028)Device: Copper IUD
- First Posted Date
- 2012-05-03
- Last Posted Date
- 2015-10-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2348
- Registration Number
- NCT01590537
To Evaluate Clinical Outcome and Injection Compliance of Scilin
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: Insulin (Scilin N, BAY81-9924)Drug: Insulin (Scilin R _BAY81-9924Drug: Insulin(Scilin M30_BAY81-9924)
- First Posted Date
- 2012-05-01
- Last Posted Date
- 2015-01-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 2683
- Registration Number
- NCT01588639
Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)
Phase 4
Completed
- Conditions
- Heartburn
- Interventions
- First Posted Date
- 2012-04-30
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 48
- Registration Number
- NCT01587885
© Copyright 2025. All Rights Reserved by MedPath